Low-dose ketamine for sickle cell pain crises in children seen in the emergency room
Tests ketamine against opioids for sickle cell pain in children and young people.
Key facts
- Who runs it
- University of Mississippi Medical Center
- Where
- Jackson, United StatesSee the site
- Trial code
- Registry title
- Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 400 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 1 Oct 2029
- Type of study
- Interventional, 2 groups
- Treatments tested
- Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses.
- Standard Care (in control arm)
- Record updated
- 6 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people with sickle cell disease who come to the emergency department with a pain crisis.
- Age
- 2 Years to 21 Years
- Sex
- All sexes can join.
- Disease stage
- Confirmed sickle cell disease of any genotype, with a vaso-occlusive (pain) crisis at the emergency department.
- Earlier treatment
- No ketamine use in the previous 24 hours.
Main reasons for not taking part
- Allergy to ketamine
- Severe agitation or psychosis
- Pregnancy
- Unstable blood circulation, as judged by the physician
- Pain not caused by a vaso-occlusive crisis (for example fever, acute chest syndrome, stroke, injury)
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Confirmed Sickle Cell Disease (any genotype), Presenting to the Emergency Department with Vaso-occlusive crisis/pain crisis, Consent obtained
Who cannot take part
- Ketamine allergy, Severe agitation/psychosis, Pregnancy, Hemodynamic instability (as judged by physician), Increased intracranial pressure, Severe hepatic impairment, Ketamine use within the previous 24 hours, Presentation for non-VOC-related pain (i.e. fever, acute chest syndrome, stroke, traumatic injuries etc)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 21 years old?
Where in United States
- University of Mississippi Medical Center, Pediatric Emergency DepartmentJackson, United StatesContact: Cynthia Karlson, Ph.D.Not yet recruiting
About the trial
What the trial wants to find out
The goal of this study is to learn if Ketamine works more efficiently, as compared to Opioids, for Sickle Cell Pain The main questions it aims to answer are:
Read full original descriptionShow less
Does Ketamine lower the number of times participants need to be admitted for continued pain control during a Sickle Cell Pain Crisis.
Does Ketamine decrease the amount of time it takes to reach adequate pain control/pain score improvement, as compared to Opioids.
Patients could have too low or too high blood pressure or sleepiness. Researchers will compare Ketamine to Opioids (Morphine or Dilaudid) to see if Ketamine works to treat pain enough that you do not need to be admitted to the hospital.
Participants will:
On arrival to the Children's ER for Sickle Cell Pain crisis will get Ketamine, instead of Morphine or Dilaudid, along with the typical Tylenol, Toradol, Lidocaine patch for pain control while in the ER.
During this time we will follow your reported pain scale (0-10) to monitor your pain response to the Ketamine, as well as follow rate of hospital admission.
The 2 groups in the trial
- Any patient with confirmed Sickle Cell Disease in pain crisis.Treatment being tested
This group will be any patient, aged 2 years until 21 years with confirmed sickle cell disease who presents to the Pediatric Emergency Department with Pain will receive multimodal pain control using Acetaminophen, Toradol, lidocaine patch, and heat packs, as well as IV Ketamine in place of Opioids.
Treatment: Standardized Low-dose bolus IV Ketamine within 30 minutes of arrival and every 1 hour as needed for max of 3 doses.
- Retrospective Historical Control GroupOther group
Treatment: Standard Care (in control arm)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Evaluation of a Standardized Low-Dose Bolus Ketamine Pathway for Management of Pediatric Sickle Cell Patients Presenting to the Emergency Department With Pain
- Plain-language title
- Low-dose ketamine for sickle cell pain crises in children seen in the emergency roomGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07682662, who can take part
- Record updated
- 6 July 2026